Filing Flows › Medifast (MED) › Q1 2025
Medifast (MED) Q1 2025 earnings results (first quarter 2025)
10-Q filed Apr 28, 2025
Medifast (MED) reported revenue of $116M for the first quarter 2025 (Q1 2025), -34% from a year earlier and -3% from the quarter before. Operating margin was -1.1%, net loss $772K (0.7% of revenue).
Medifast, Q1 2025: revenue $116M (-34% year over year), operating margin -1.1%, net loss $772K, operating cash flow $3.4M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $116M | -3% | -34% |
| Operating profit | −$1.3M | — | — |
| Net earnings | −$772K | — | — |
| Operating cash flow | $3.4M | — | -53% |
| Free cash flow | $1.9M | — | -65% |
What changed
Revenue was $115.7M in Q1 2025, down 34% year over year and down 3% from the previous quarter.
Gross margin was 72.8%, down 0.1 points from a year earlier. Operating costs exceeded revenue by $1.3M, an operating margin of -1.1%. Operating expenses fell 28% while revenue fell 34%. The quarter ended with a net loss of $772K, after a profit of $801K the previous quarter. Non-operating items added $1.8M, 340% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was $3.4M (down 53% year over year). Non-cash charges added back $3.3M of depreciation and amortization and $1.9M of share-based compensation. Working capital and other items used $1.0M. Capital expenditures of $1.5M left free cash flow of $1.9M.
Questions
What was Medifast's revenue in the first quarter 2025?
Medifast (MED) reported revenue of $116M for the first quarter 2025 (Q1 2025), -34% from a year earlier and -3% from the quarter before.
Was Medifast profitable in the first quarter 2025?
Operating loss was $1.3M (-1.1% of revenue) and net loss $772K.
Source: Medifast 10-Q on SEC EDGAR.